There have been 50 recent insider transactions recorded for Miromatrix Medical Inc. (MIRO), including 29 buys and 18 sells. Total insider buying was valued at $999.39K and total insider selling at $2.08M.
Notable insiders with recent activity include Kattungal Laji, Erb John L, Buckman Paul. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — MIRO
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2024-07-16 |
Kattungal Laji |
Vice President of Quality |
Disposition |
80,000 |
$3.75 |
$300K |
- |
| 2023-12-13 |
Erb John L |
Director |
Return of Shares |
25,000 |
$3.75 |
$93.75K |
- |
| 2023-12-13 |
Buckman Paul |
Director |
Return of Shares |
25,000 |
$3.75 |
$93.75K |
- |
| 2023-12-13 |
Maag Peter |
Director |
Return of Shares |
58,368 |
- |
- |
- |
| 2023-12-13 |
Burke William P. Mr. |
Director |
Return of Shares |
67,413 |
- |
- |
- |
| 2023-12-13 |
Heine Lisa Wipperman |
Director |
Return of Shares |
67,413 |
- |
- |
- |
| 2023-12-13 |
Ross Jeffrey James |
Chief Executive Officer |
Return of Shares |
100,000 |
$3.26 |
$326K |
- |
| 2023-12-13 |
Douglas James Michael |
Chief Financial Officer |
Return of Shares |
40,000 |
$3.26 |
$130.4K |
- |
| 2023-12-12 |
Erb John L |
Director |
Tender Offer (Sell) |
56,260 |
$1.75 |
$98.46K |
54,201 |
| 2023-12-12 |
Buckman Paul |
Director |
Tender Offer (Sell) |
52,593 |
$1.75 |
$92.04K |
54,201 |
| 2023-12-12 |
Maag Peter |
Director |
Tender Offer (Sell) |
62,092 |
$1.75 |
$108.66K |
58,368 |
| 2023-12-12 |
Burke William P. Mr. |
Director |
Tender Offer (Sell) |
66,943 |
$1.75 |
$117.15K |
67,413 |
| 2023-12-12 |
Heine Lisa Wipperman |
Director |
Tender Offer (Sell) |
66,943 |
$1.75 |
$117.15K |
67,413 |
| 2023-12-12 |
Ross Jeffrey James |
Chief Executive Officer |
Tender Offer (Sell) |
308,775 |
$1.75 |
$540.36K |
87,500 |
| 2023-12-12 |
Douglas James Michael |
Chief Financial Officer |
Tender Offer (Sell) |
31,250 |
$1.75 |
$54.69K |
20,000 |
| 2023-12-12 |
United Therapeutics Corp |
10 Percent Owner |
Disposition |
- |
- |
- |
27,419,228 |
| 2023-06-01 |
Erb John L |
Director |
RSU Award |
54,201 |
- |
- |
110,461 |
| 2023-06-01 |
Buckman Paul |
Director |
RSU Award |
54,201 |
- |
- |
106,794 |
| 2023-06-01 |
Maag Peter |
Director |
RSU Award |
54,201 |
- |
- |
120,460 |
| 2023-06-01 |
Burke William P. Mr. |
Director |
RSU Award |
54,201 |
- |
- |
134,356 |
| 2023-06-01 |
Heine Lisa Wipperman |
Director |
RSU Award |
54,201 |
- |
- |
134,356 |
| 2023-03-10 |
Erb John L |
Director |
Informative Buy |
31,250 |
$1.60 |
$50K |
56,260 |
| 2023-03-10 |
Buckman Paul |
Director |
Informative Buy |
31,250 |
$1.60 |
$50K |
52,593 |
| 2023-03-10 |
Maag Peter |
Director |
Informative Buy |
31,250 |
$1.60 |
$50K |
66,259 |
| 2023-03-10 |
Burke William P. Mr. |
Director |
Informative Buy |
31,250 |
$1.60 |
$50K |
80,155 |
| 2023-03-10 |
Heine Lisa Wipperman |
Director |
Informative Buy |
31,250 |
$1.60 |
$50K |
80,155 |
| 2023-03-10 |
Ross Jeffrey James |
Chief Executive Officer |
Informative Buy |
31,250 |
$1.60 |
$50K |
396,276 |
| 2023-03-10 |
Barry John Joseph |
Vice President of R&d |
Informative Buy |
6,250 |
$1.60 |
$10K |
35,485 |
| 2023-03-10 |
Douglas James Michael |
Chief Financial Officer |
Informative Buy |
31,250 |
$1.60 |
$50K |
51,250 |
| 2023-01-13 |
Ross Jeffrey James |
Chief Executive Officer |
RSU Award |
100,000 |
- |
- |
100,000 |
| 2023-01-13 |
Barry John Joseph |
Vice President of R&d |
RSU Award |
20,000 |
- |
- |
20,000 |
| 2023-01-13 |
Douglas James Michael |
Chief Financial Officer |
RSU Award |
20,000 |
- |
- |
20,000 |
| 2022-12-06 |
Ross Jeffrey James |
Chief Executive Officer |
Option Exercise (Sell) |
37,500 |
- |
- |
- |
| 2022-10-01 |
Barry John Joseph |
Vice President of R&d |
Tax Withholding of RSU |
765 |
$4.38 |
$3.35K |
19,235 |
| 2022-08-10 |
Erb John L |
Director |
RSU Award |
12,788 |
- |
- |
25,010 |
| 2022-08-10 |
Buckman Paul |
Director |
RSU Award |
12,788 |
- |
- |
21,343 |
| 2022-08-10 |
Maag Peter |
Director |
RSU Award |
12,788 |
- |
- |
35,009 |
| 2022-08-10 |
Burke William P. Mr. |
Director |
RSU Award |
12,788 |
- |
- |
48,905 |
| 2022-08-10 |
Heine Lisa Wipperman |
Director |
RSU Award |
12,788 |
- |
- |
48,905 |
| 2022-03-15 |
Ross Jeffrey James |
Chief Executive Officer |
Option Exercise |
35,438 |
$1.25 |
$44.3K |
293,588 |
| 2022-03-01 |
Douglas James Michael |
Officer |
Unknown |
- |
- |
- |
- |
| 2022-03-01 |
Douglas James Michael |
Chief Financial Officer |
RSU Award |
180,000 |
- |
- |
180,000 |
| 2022-01-13 |
Niebur Brian |
Chief Financial Officer |
RSU Award |
20,000 |
$4.20 |
$84K |
20,000 |
| 2022-01-13 |
Kattungal Laji |
Vice President of Quality |
RSU Award |
10,000 |
- |
- |
10,000 |
| 2022-01-13 |
Ross Jeffrey James |
Chief Executive Officer |
RSU Award |
100,000 |
$4.20 |
$420K |
100,000 |
| 2022-01-13 |
Barry John Joseph |
Vice President of R&d |
RSU Award |
20,000 |
$4.20 |
$84K |
20,000 |
| 2022-01-03 |
Niebur Brian |
Chief Financial Officer |
RSU Award |
1,500 |
$4.73 |
$7.1K |
1,500 |
| 2022-01-03 |
Burke William P. Mr. |
Director |
Unknown |
- |
- |
- |
- |
| 2022-01-03 |
Burke William P. Mr. |
Director |
RSU Award |
4,405 |
- |
- |
4,405 |
| 2022-01-03 |
Heine Lisa Wipperman |
Director |
Unknown |
- |
- |
- |
- |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry